Cost-effectiveness of adding rituximab to splenectomy and romiplostim for treating steroid-resistant idiopathic thrombocytopenic purpura in adults

BACKGROUND: Idiopathic thrombocytopenic purpura (ITP) is an autoimmune disease in which the platelet count falls to <100 × 10(9)/L. Corticosteroids are recommended as the first-line treatment, splenectomy is recommended as the second-line treatment, and thrombopoietin receptor agonists (TPO-RAs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Kikuchi, Kayoko, Miyakawa, Yoshitaka, Ikeda, Shunya, Sato, Yuji, Takebayashi, Toru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/
https://www.ncbi.nlm.nih.gov/pubmed/25609557
http://dx.doi.org/10.1186/s12913-015-0681-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307915/
https://www.ncbi.nlm.nih.gov/pubmed/25609557
http://dx.doi.org/10.1186/s12913-015-0681-y

Ejemplares similares